finance

Stifel upgrades Fulcrum Therapeutics to 'buy' with a price target of $11.00




Stifel upgrades Fulcrum Therapeutics to 'buy' with a price target of $11.00



READ SOURCE

Readers Also Like:  BrewDog drops pledge to pay all staff living wage

This website uses cookies. By continuing to use this site, you accept our use of cookies.